PET/CT对HPV相关口咽癌AJCC第8版病理分期预测不佳
两位神经放射科医生盲法重新评估扫描,结果显示PET/CT倾向于过度分期淋巴结和总体分期,且对淋巴结外侵犯预测准确性差。
要点
- PET/CT对HPV阳性口咽癌的淋巴结和总体分期常高于病理分期。
- PET/CT不应作为初始肿瘤分期的唯一依据。
- PET/CT对淋巴结外侵犯的预测准确性差。
核心结论
- PET/CT预测的淋巴结和总体分期高于病理分期。
- PET/CT不应依赖用于初始肿瘤分期,因为FDG摄取增高对淋巴结转移不特异。
- PET/CT对淋巴结外侵犯的预测效果差。
研究设计与样本
- 两位神经放射科医生对所有术前PET/CT扫描进行盲法重新评估,记录原发肿瘤大小和颈部淋巴结特征并推断TNM分期。
- 使用Cohen kappa统计量评估评分者间信度,对称性检验分析放射学与病理分期的差异。
主要发现
- 放射科医生A评估的总体分期与病理分期一致率为67%,过度分期31%,分期不足2%。
- 放射科医生B评估的总体分期一致率为61%,过度分期39%,分期不足0%。
- 在错误分类的病例中,对称性检验显示淋巴结分期和总体分期强烈倾向于过度分期(P < .001)。
- 淋巴结和总体分期的评分者间信度分别为κ = 0.715和0.715,为显著一致。
- 放射学对淋巴结外侵犯的评估评分者间信度差(κ = 0.403),准确性差。
临床怎么用
- 临床医生应谨慎使用PET/CT进行HPV阳性口咽癌的初始分期,避免过度分期。
- PET/CT结果不应替代病理分期,尤其对于淋巴结外侵犯的评估。
局限性
- 证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The American Joint Committee on Cancer (AJCC) 8th edition introduced distinct clinical and pathological staging paradigms for human papilloma virus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC). Treatment planning for OPSCC often utilizes positron emission tomography/computed tomography (PET/CT) to assess clinical stage. We hypothesize that PET/CT will accurately predict final pathologic AJCC 8th edition staging in patients with HPV+ OPSCC. METHODS: All patients with primary HPV+ OPSCC with preoperative PET/CT who underwent transoral robotic surgery and neck dissection between 2011 and 2017 were identified. Data were collected via chart review. Two neuroradiologists performed blinded re-evaluation of all scans. Primary tumor size and cervical nodal disease characteristics were recorded and TNM staging was extrapolated. Cohen's kappa statistic was used to assess interrater reliability. Test for symmetry was performed to analyze discordance between radiologic and pathologic staging. RESULTS: Forty-nine patients met inclusion criteria. Interrater reliability was substantial between radiologists for nodal (N) and overall staging (OS) (κ = 0.715 and 0.715). Radiologist A review resulted in identical OS for 67% of patients, overstaging for 31%, and understaging for 2%. Radiologist B review resulted in 61% identical OS, 39% overstaging, and 0% understaging. In misclassified cases, the test of symmetry shows strong bias toward overstaging N stage and OS (P < .001). Radiologic interpretation of extracapsular extension showed poor interrater reliability (κ = 0.403) and poor accuracy. CONCLUSION: PET/CT predicts a higher nodal and overall stage than pathologic staging. PET/CT should not be relied upon for initial tumor staging, as increased FDG uptake is not specific for nodal metastases. PET/CT is shown to be a poor predictor of ECE. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:1535-1541, 2021.
引用
- Snyder V, Goyal LK, Bowers EMR, et al. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer. Laryngoscope. 2021. PMID: 33428218. doi:10.1002/lary.29366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。